BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9793832)

  • 81. [Screening test for prostate cancer].
    Imai K; Kubota Y; Yamanaka H
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1923-7. PubMed ID: 7522000
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients?
    Sorum PC; Shim J; Chasseigne G; Bonnin-Scaon S; Cogneau J; Mullet E
    Med Decis Making; 2003; 23(4):301-13. PubMed ID: 12926580
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Relevance of total PSA and free PSA prescriptions.
    Lamy PJ; Brouillet JP; Bermont L; Fouillet G; Loric S
    Ann Biol Clin (Paris); 2018 Dec; 76(6):659-663. PubMed ID: 30543191
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Documentation of preventive screening interventions by general practitioners: a retrospective chart audit.
    Ngwakongnwi E; Hemmelgarn B; Quan H
    BMC Fam Pract; 2010 Mar; 11():21. PubMed ID: 20214813
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
    Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
    Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam).
    Beemsterboer PM; Kranse R; de Koning HJ; Habbema JD; Schröder FH
    Int J Cancer; 1999 Aug; 84(4):437-41. PubMed ID: 10404100
    [TBL] [Abstract][Full Text] [Related]  

  • 88. PSA testing for men at average risk of prostate cancer.
    Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Local screening program for prostate cancer].
    Kotsev R; Kolev N; Stratev S; Mikhailov O
    Khirurgiia (Sofiia); 2000; 56(5-6):52-4. PubMed ID: 11692936
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.
    Walsh AL; Considine SW; Thomas AZ; Lynch TH; Manecksha RP
    Br J Gen Pract; 2014 Dec; 64(629):e783-7. PubMed ID: 25452543
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
    Amin HS; Arafa MA; Farhat KH; Rabah DM; Altaweel AA; Alhammad AH
    Afr Health Sci; 2020 Dec; 20(4):1870-1874. PubMed ID: 34394251
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Family physician's knowledge, beliefs, and self-reported practice patterns regarding hyperlipidemia: a National Research Network (NRN) survey.
    Eaton CB; Galliher JM; McBride PE; Bonham AJ; Kappus JA; Hickner J
    J Am Board Fam Med; 2006; 19(1):46-53. PubMed ID: 16492005
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Knowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community.
    Livingston P; Cohen P; Frydenberg M; Borland R; Reading D; Clarke V; Hill D
    Intern Med J; 2002; 32(5-6):215-23. PubMed ID: 12036219
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.
    Mercer SL; Goel V; Levy IG; Ashbury FD; Iverson DC; Iscoe NA
    Can J Public Health; 1997; 88(5):327-32. PubMed ID: 9401168
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Attitudes and knowledge of primary care physicians regarding prostate cancer screening.
    Johnson K; Chang M; Sun Y; Miyake M; Rosser CJ
    J Cancer Educ; 2013 Dec; 28(4):679-83. PubMed ID: 23963724
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Perceptions of Iowa family physicians regarding colorectal cancer screening.
    Levy BT; Joshi M; Xu Y; Daly J; James PA
    Med Care; 2008 Sep; 46(9 Suppl 1):S103-8. PubMed ID: 18725821
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study.
    Guerra CE; Jacobs SE; Holmes JH; Shea JA
    J Gen Intern Med; 2007 Jul; 22(7):901-7. PubMed ID: 17549576
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Colorectal cancer screening by general practitioners: comparison with national guidelines.
    Olynyk JK; Aquilia S; Platell CF; Fletcher DR; Henderson S; Dickinson JA
    Med J Aust; 1998 Apr; 168(7):331-4. PubMed ID: 9577443
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Physician and patient predictors of health maintenance visits.
    Preisser JS; Cohen SJ; Wofford JL; Moran WP; Shelton BJ; McClatchey MW; Wolfe P
    Arch Fam Med; 1998; 7(4):346-51. PubMed ID: 9682688
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A test of knowledge about prostate cancer screening. Online pilot evaluation among Southern California Physicians.
    Bell DS; Hays RD; Hoffman JR; Day FC; Higa JK; Wilkes MS
    J Gen Intern Med; 2006 Apr; 21(4):310-4. PubMed ID: 16499545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.